TrialBMC pulmonary medicine2017

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.

Pradeesh Sivapalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.